Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2025-12-24 @ 12:44 PM
NCT ID:
NCT06111261
Eligibility Criteria:
Inclusion Criteria:
* Adult patients (19 or older)
* Admitted or planned to admit surgical intensive care unit
* Patients with decreased hemoglobin level more than 20% from baseline within 12 hours, Or
* Patients who are suspected bleeding and hemodynamically unstable requiring more than 0.05mcg/kg/min of norepinephrine infusion to maintain mean blood pressure higher than 65mmHg
Exclusion Criteria:
* Contraindicated to albumin product
* patients with risk factors of increased circulatory volume (heart failure, pulmonary edema, end-stage renal disease with oliguria)
* patients with hemolytic anemia
* History of anaphylactic reaction to blood product
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT06111261
Study Brief:
Protocol Section:
NCT06111261